Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Carolien Konijnenberg, Ingunn Olea Lund & Annika Melinder. (2015) Behavioural outcomes of four-year-old children prenatally exposed to methadone or buprenorphine: a test of three risk models. Early Child Development and Care 185:10, pages 1641-1657.
Read now
Read now
Kristin Johanne Haabrekke, Kari Slinning, Kristine Beate Walhovd, Tore Wentzel-Larsen & Vibeke Moe. (2014) The Perinatal Outcome of Children Born to Women With Substance Dependence Detoxified in Residential Treatment During Pregnancy. Journal of Addictive Diseases 33:2, pages 114-123.
Read now
Read now
Robert G. Newman & Susan G. Gevertz. (2013) Fetal abstinence: differing viewpoints?. The Journal of Maternal-Fetal & Neonatal Medicine 26:1, pages 109-109.
Read now
Read now
Hendrée E. Jones, Karol Kaltenbach, Sarah H. Heil, Susan M. Stine, Mara G. Coyle, Amelia M. Arria, Kevin E. O’Grady, Peter Selby, Peter R. Martin, Lauren Jansson & Gabriele Fischer. (2012) Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?. The Journal of Maternal-Fetal & Neonatal Medicine 25:7, pages 1197-1201.
Read now
Read now
Articles from other publishers (22)
Isabelle Zerfas, Reagan McGinn & Michael A. Smith. (2023) Pharmacologic Management of Cancer-Related Pain in Pregnant Patients. Drugs 83:12, pages 1067-1076.
Crossref
Crossref
Konijnenberg Carolien & Melinder Annika. (2021) Affective decision‐making in children prenatally exposed to opioids. Scandinavian Journal of Psychology 62:4, pages 529-536.
Crossref
Crossref
Madison IrwinKetti S. PetersenMichael A. Smith. (2021) Rapid Buprenorphine Induction for Cancer Pain in Pregnancy. Journal of Palliative Medicine 24:8, pages 1257-1262.
Crossref
Crossref
Jannike Mørch Andersen, Gudrun Høiseth & Egil Nygaard. (2020) Prenatal exposure to methadone or buprenorphine and long-term outcomes: A meta-analysis. Early Human Development 143, pages 104997.
Crossref
Crossref
Carolien Konijnenberg & Annika Melinder. (2020) Salivary cortisol levels relate to cognitive performance in children prenatally exposed to methadone or buprenorphine. Developmental Psychobiology 62:3, pages 409-418.
Crossref
Crossref
Nete Lundager Klokker Rausgaard, Inge Olga Ibsen, Jan Stener Jørgensen, Ronald Francis Lamont & Pernille Ravn. (2019) Management and monitoring of opioid use in pregnancy. Acta Obstetricia et Gynecologica Scandinavica 99:1, pages 7-15.
Crossref
Crossref
Awais Aftab & Asim A. Shah. (2017) Behavioral Emergencies. Psychiatric Clinics of North America 40:3, pages 435-448.
Crossref
Crossref
Erin Kelty & Gary Hulse. (2017) A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls. Drugs 77:11, pages 1199-1210.
Crossref
Crossref
John J. McCarthy, Martin H. Leamon, Loretta P. Finnegan & Catherine Fassbender. (2017) Opioid dependence and pregnancy: minimizing stress on the fetal brain. American Journal of Obstetrics and Gynecology 216:3, pages 226-231.
Crossref
Crossref
S. Hultzsch & C. Schaefer. (2016) Schmerzmedikation in der SchwangerschaftAnalgesic drugs during pregnancy. Der Schmerz 30:6, pages 583-593.
Crossref
Crossref
John J. McCarthy & Mishka Terplan. (2016) Detoxification from opiates during pregnancy: stressing the fetal brain. American Journal of Obstetrics and Gynecology 215:5, pages 670.e1-670.e2.
Crossref
Crossref
Gabrielle K. Welle-Strand, Svetlana Skurtveit, Lars Tanum, Helge Waal, Brittelise Bakstad, Lisa Bjarkø & Edle Ravndal. (2015) Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009. European Addiction Research 21:5, pages 253-261.
Crossref
Crossref
G. K. Welle-Strand, O. Kvamme, A. Andreassen & E. Ravndal. (2014) A woman's experience of tapering from buprenorphine during pregnancy. Case Reports 2014:dec24 1, pages bcr2014207207-bcr2014207207.
Crossref
Crossref
C. Falch, D. Vicente, H. Häberle, A. Kirschniak, S. Müller, A. Nissan & B.L.D.M. Brücher. (2014) Treatment of acute abdominal pain in the emergency room: A systematic review of the literature. European Journal of Pain 18:7, pages 902-913.
Crossref
Crossref
Leena Mittal. (2014) Buprenorphine for the Treatment of Opioid Dependence in Pregnancy. Journal of Perinatal & Neonatal Nursing 28:3, pages 178-184.
Crossref
Crossref
Kaitlyn Delano, Joey Gareri & Gideon Koren. (2013) Rates of Fetal Polydrug Exposures in Methadone-Maintained Pregnancies from a High-Risk Population. PLoS ONE 8:12, pages e82647.
Crossref
Crossref
Michael Soyka. (2013) Buprenorphine Use in Pregnant Opioid Users: A Critical Review. CNS Drugs 27:8, pages 653-662.
Crossref
Crossref
Brian J. Cleary, Kieran Reynolds, Maeve Eogan, Michael P. O'Connell, Tom Fahey, Paul J. Gallagher, Tom Clarke, Martin J. White, Christine McDermott, Anne O'Sullivan, Deirdre Carmody, Justin Gleeson & Deirdre J. Murphy. (2013) Methadone dosing and prescribed medication use in a prospective cohort of opioid‐dependent pregnant women. Addiction 108:4, pages 762-770.
Crossref
Crossref
Denise Maguire. (2013) Drug Addiction in Pregnancy: Disease Not Moral Failure. Neonatal Network 33:1, pages 11-18.
Crossref
Crossref
Gabrielle K. Welle-Strand, Svetlana Skurtveit, Hendreé E. Jones, Helge Waal, Brittelise Bakstad, Lisa Bjarkø & Edle Ravndal. (2013) Neonatal outcomes following in utero exposure to methadone or buprenorphine: A National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Drug and Alcohol Dependence 127:1-3, pages 200-206.
Crossref
Crossref
Emmalee S. Bandstra. (2012) Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses. Addiction 107, pages 1-4.
Crossref
Crossref
Sadie Geraghty & Carly Dixon. (2012) The use of naltrexone in pregnancy in opiate-dependent mothers. British Journal of Midwifery 20:7, pages 503-506.
Crossref
Crossref